WEN-JEN HWU to Confidence Intervals
This is a "connection" page, showing publications WEN-JEN HWU has written about Confidence Intervals.
Connection Strength
0.051
-
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol. 2018 02; 19(2):181-193.
Score: 0.035
-
A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma. Melanoma Res. 1997 Apr; 7(2):147-51.
Score: 0.016